Agios Pharmaceuticals Inc (AGIO)
Sector • Healthcare Industry • Major Pharmaceutical Preparations |
Industry • Major Pharmaceutical Preparations |
Sector • Healthcare |
News
Revolutionizing Sickle Cell Treatment: Agios Reports Amplifying Results in RISE UP Pivotal Study
Agios Pharmaceuticals Inc*s Deficit Widens to $-1.69 Million in Fiscal Year Ending December 31, 2023
Agios Pharmaceuticals Fails to Break Even Despite Record Revenue Surge in Q3 2023
Outstanding evolution by Agios Pharmaceuticals Inc in the second quarter of 2023 earnings season
The company released Revenue of $4.31 millions, in the October to December 31 2022